Neelam, A., & Kanaki, A. (2021). Efficacy and safety of remogliflozin etabonate in type 2 diabetes mellitus patients in a tertiary care hospital. International Journal of Basic & Clinical Pharmacology, 10(4), 353–356. https://doi.org/10.18203/2319-2003.ijbcp20211014